{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T23:07:40Z","timestamp":1791587260904,"version":"4.3.4"},"reference-count":130,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"NIH","award":["R21 HD107535"],"award-info":[{"award-number":["R21 HD107535"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Prader\u2013Willi (PWS) and Angelman (AS) syndromes were the first examples in humans with errors in genomic imprinting, usually from de novo 15q11-q13 deletions of different parent origin (paternal in PWS and maternal in AS). Dozens of genes and transcripts are found in the 15q11-q13 region, and may play a role in PWS, specifically paternally expressed SNURF-SNRPN and MAGEL2 genes, while AS is due to the maternally expressed UBE3A gene. These three causative genes, including their encoding proteins, were targeted. This review article summarizes and illustrates the current understanding and cause of both PWS and AS using strategies to include the literature sources of key words and searchable web-based programs with databases for integrated gene and protein interactions, biological processes, and molecular mechanisms available for the two imprinting disorders. The SNURF-SNRPN gene is key in developing complex spliceosomal snRNP assemblies required for mRNA processing, cellular events, splicing, and binding required for detailed protein production and variation, neurodevelopment, immunodeficiency, and cell migration. The MAGEL2 gene is involved with the regulation of retrograde transport and promotion of endosomal assembly, oxytocin and reproduction, as well as circadian rhythm, transcriptional activity control, and appetite. The UBE3A gene encodes a key enzyme for the ubiquitin protein degradation system, apoptosis, tumor suppression, cell adhesion, and targeting proteins for degradation, autophagy, signaling pathways, and circadian rhythm. PWS is characterized early with infantile hypotonia, a poor suck, and failure to thrive with hypogenitalism\/hypogonadism. Later, growth and other hormone deficiencies, developmental delays, and behavioral problems are noted with hyperphagia and morbid obesity, if not externally controlled. AS is characterized by seizures, lack of speech, severe learning disabilities, inappropriate laughter, and ataxia. This review captures the clinical presentation, natural history, causes with genetics, mechanisms, and description of established laboratory testing for genetic confirmation of each disorder. Three separate searchable web-based programs and databases that included information from the updated literature and other sources were used to identify and examine integrated genetic findings with predicted gene and protein interactions, molecular mechanisms and functions, biological processes, pathways, and gene-disease associations for candidate or causative genes per disorder. The natural history, review of pathophysiology, clinical presentation, genetics, and genetic-phenotypic findings were described along with computational biology, molecular mechanisms, genetic testing approaches, and status for each disorder, management and treatment options, clinical trial experiences, and future strategies. Conclusions and limitations were discussed to improve understanding, clinical care, genetics, diagnostic protocols, therapeutic agents, and genetic counseling for those with these genomic imprinting disorders.<\/jats:p>","DOI":"10.3390\/ijms27031270","type":"journal-article","created":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T15:41:56Z","timestamp":1769528516000},"page":"1270","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Clinical Presentation, Genetics, and Laboratory Testing with Integrated Genetic Analysis of Molecular Mechanisms in Prader\u2013Willi and Angelman Syndromes: A Review"],"prefix":"10.3390","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2911-0524","authenticated-orcid":false,"given":"Merlin G.","family":"Butler","sequence":"first","affiliation":[{"name":"Departments of Psychiatry, Behavioral Sciences and Pediatrics, University of Kansas Medical Center, Kansas City, KS 66160, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,1,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/ajmg.1320350306","article-title":"Prader\u2013Willi syndrome: Current understanding of cause and diagnosis","volume":"35","author":"Butler","year":"1990","journal-title":"Am. J. Med. Genet."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"3S","DOI":"10.1097\/00019616-200010041-00002","article-title":"Prader\u2013Willi Syndrome: Clinical and Genetic Findings","volume":"10","author":"Butler","year":"2000","journal-title":"Endocrinologist"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1136\/jmg.40.2.87","article-title":"Angelman syndrome: A review of the clinical and genetic aspects","volume":"40","author":"Laan","year":"2003","journal-title":"J. Med. Genet."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399405009531","article-title":"Prader\u2013Willi syndrome: Clinical genetics, cytogenetics and molecular biology","volume":"7","author":"Bittel","year":"2005","journal-title":"Expert Rev. Mol. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/GIM.0b013e3181def138","article-title":"Clinical and genetic aspects of Angelman syndrome","volume":"12","author":"Williams","year":"2010","journal-title":"Genet. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/gim.0b013e31822bead0","article-title":"Prader\u2013Willi syndrome","volume":"14","author":"Cassidy","year":"2012","journal-title":"Genet. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2147\/TACG.S57386","article-title":"Angelman syndrome: Review of clinical and molecular aspects","volume":"7","author":"Bird","year":"2014","journal-title":"Appl. Clin. Genet."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s13311-015-0361-y","article-title":"Angelman Syndrome","volume":"12","author":"Margolis","year":"2015","journal-title":"Neurotherapeutics"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/ejhg.2014.93","article-title":"Clinical utility gene card for: Angelman Syndrome","volume":"23","author":"Buiting","year":"2015","journal-title":"Eur. J. Hum. Genet."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1891\/0730-0832.36.3.142","article-title":"Angelman Syndrome: Identification and Management","volume":"36","author":"Bonello","year":"2017","journal-title":"Neonatal. Netw."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Butler, M.G., and Duis, J. (2020). Chromosome 15 Imprinting Disorders: Genetic Laboratory Methodology and Approaches. Front. Pediatr., 8.","DOI":"10.3389\/fped.2020.00154"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1097\/MOP.0000000000000965","article-title":"Imprinting disorders in humans: A review","volume":"32","author":"Butler","year":"2020","journal-title":"Curr. Opin. Pediatr."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Noordam, C., H\u00f6ybye, C., and Eiholzer, U. (2021). Prader\u2013Willi Syndrome and Hypogonadism: A Review Article. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22052705"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Butler, M.G., Lee, P.D.K., and Whitman, B.Y. (2022). Management of Prader\u2013Willi Syndrome, Springer Nature. [4th ed.].","DOI":"10.1007\/978-3-030-98171-6"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.pmbts.2015.12.003","article-title":"Single Gene and Syndromic Causes of Obesity: Illustrative Examples","volume":"140","author":"Butler","year":"2016","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Butler, M.G. (2023). Prader\u2013Willi Syndrome and Chromosome 15q11.2 BP1-BP2 Region: A Review. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24054271"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"200195","DOI":"10.1098\/rsob.200195","article-title":"Prader\u2013Willi syndrome: Reflections on seminal studies and future therapies","volume":"10","author":"Chung","year":"2020","journal-title":"Open Biol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13023-023-02633-5","article-title":"The Italian registry for patients with Prader\u2013Willi syndrome","volume":"18","author":"Salvatore","year":"2023","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/cge.14477","article-title":"Genotype-phenotype correlation in Prader\u2013Willi syndrome: A large-sample analysis in China","volume":"105","author":"Mao","year":"2024","journal-title":"Clin. Genet."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/YCO.0000000000000981","article-title":"Genetics of Prader\u2013Willi and Angelman syndromes: 2024 update","volume":"38","author":"Godler","year":"2025","journal-title":"Curr. Opin. Psychiatry"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/01.JAA.0000000000000079","article-title":"A review of Prader\u2013Willi syndrome","volume":"38","author":"Metzler","year":"2025","journal-title":"JAAPA"},{"key":"ref_22","unstructured":"Jones, K.L., Jones, M.C., and Del Campo, M. (2013). Smith\u2019s Recognizable Patterns of Human Malformation, Elsevier Saunders. [7th ed.]."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1136\/jmedgenet-2018-105301","article-title":"Molecular genetic classification in Prader\u2013Willi syndrome: A multisite cohort study","volume":"56","author":"Butler","year":"2019","journal-title":"J. Med. Genet."},{"key":"ref_24","unstructured":"Adam, M.P., Feldman, J., Mirzaa, G.M., Pagon, R.A., Wallace, S.E., and Amemiya, A. (2024). Prader\u2013Willi Syndrome. GeneReviews\u00ae\u00ae [Internet], University of Washington."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"204","DOI":"10.2174\/138920211795677877","article-title":"Prader\u2013Willi Syndrome: Obesity due to Genomic Imprinting","volume":"12","author":"Butler","year":"2011","journal-title":"Curr. Genom."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2174\/1573396315666190716120925","article-title":"Prader\u2013Willi Syndrome\u2014Clinical Genetics, Diagnosis and Treatment Approaches: An Update","volume":"15","author":"Butler","year":"2019","journal-title":"Curr. Pediatr. Rev."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e2101154","DOI":"10.1002\/adbi.202101154","article-title":"Syndromic and Nonsyndromic Obesity: Underlying Genetic Causes in Humans","volume":"6","author":"Duis","year":"2022","journal-title":"Adv. Biol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1542\/peds.113.3.565","article-title":"Behavioral differences among subjects with Prader\u2013Willi syndrome and type I or type II deletion and maternal disomy","volume":"113","author":"Butler","year":"2004","journal-title":"Pediatrics"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e1276-83","DOI":"10.1542\/peds.2006-0424","article-title":"Expression of 4 genes between chromosome 15 breakpoints 1 and 2 and behavioral outcomes in Prader\u2013Willi syndrome","volume":"118","author":"Bittel","year":"2006","journal-title":"Pediatrics"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.neubiorev.2018.10.006","article-title":"A review of psychiatric conceptions of mental and behavioural disorders in Prader\u2013Willi syndrome","volume":"95","author":"Whittington","year":"2018","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s13023-024-03026-y","article-title":"Psychotic illness in people with Prader\u2013Willi syndrome: A systematic review of clinical presentation, course and phenomenology","volume":"19","author":"Aman","year":"2024","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Dodet, P., Sanapo, F., Leu-Semenescu, S., Coupaye, M., Bellicha, A., Arnulf, I., Poitou, C., and Redolfi, S. (2022). Sleep Disorders in Adults with Prader\u2013Willi Syndrome: Review of the Literature and Clinical Recommendations Based on the Experience of the French Reference Centre. J. Clin. Med., 11.","DOI":"10.3390\/jcm11071986"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.pediatrneurol.2021.07.009","article-title":"Evaluating Sleep Disturbances in Children With Rare Genetic Neurodevelopmental Syndromes","volume":"123","author":"Veatch","year":"2021","journal-title":"Pediatr. Neurol."},{"key":"ref_34","first-page":"1260","article-title":"Ein syndrome von adipositas, kleinwuchs, kyrptorchismus und oligophrenie nach myatonieraratigen zustand im neugeborenalter","volume":"86","author":"Prader","year":"1956","journal-title":"Schweiz. Med. Wochenschr."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1002\/ajmg.a.33951","article-title":"Nutritional phases in Prader\u2013Willi syndrome","volume":"155","author":"Miller","year":"2011","journal-title":"Am. J. Med. Genet. A"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"104379","DOI":"10.1016\/j.ejmg.2021.104379","article-title":"The consequences of hyperphagia in people with Prader\u2013Willi Syndrome: A systematic review of studies of morbidity and mortality","volume":"65","author":"Bellis","year":"2022","journal-title":"Eur. J. Med. Genet."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Calcaterra, V., Magenes, V.C., Destro, F., Baldassarre, P., Silvestro, G.S., Tricella, C., Visioli, A., Verduci, E., Pelizzo, G., and Zuccotti, G. (2023). Prader\u2013Willi Syndrome and Weight Gain Control: From Prevention to Surgery-A Narrative Review. Children, 10.","DOI":"10.3390\/children10030564"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/gim.2016.178","article-title":"Causes of death in Prader\u2013Willi syndrome: Prader\u2013Willi Syndrome Association (USA) 40-year mortality survey","volume":"19","author":"Butler","year":"2017","journal-title":"Genet. Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/gim.2017.92","article-title":"Survival trends from the Prader\u2013Willi Syndrome Association (USA) 40-year mortality survey","volume":"20","author":"Manzardo","year":"2018","journal-title":"Genet. Med."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Butler, M.G., Oyetunji, A., and Manzardo, A.M. (2020). Age Distribution, Comorbidities and Risk Factors for Thrombosis in Prader\u2013Willi Syndrome. Genes, 11.","DOI":"10.3390\/genes11010067"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.cell.2019.01.043","article-title":"Genomic Imprinting and Physiological Processes in Mammals","volume":"176","author":"Tucci","year":"2019","journal-title":"Cell"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0165-3806(95)00209-X","article-title":"Genomic imprinting and the differential roles of parental genomes in brain development","volume":"92","author":"Keverne","year":"1996","journal-title":"Brain Res. Dev. Brain Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/nrg3766","article-title":"The role of genomic imprinting in biology and disease: An expanding view","volume":"15","author":"Peters","year":"2014","journal-title":"Nat. Rev. Genet."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s10815-014-0411-0","article-title":"Clinically relevant known and candidate genes for obesity and their overlap with human infertility and reproduction","volume":"32","author":"Butler","year":"2015","journal-title":"J. Assist. Reprod. Genet."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1172\/JCI88648","article-title":"Deficiency in prohormone convertase PC1 impairs prohormone processing in Prader\u2013Willi syndrome","volume":"127","author":"Burnett","year":"2017","journal-title":"J. Clin. Investig."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"BSR20220610","DOI":"10.1042\/BSR20220610","article-title":"Proteins and proteases of Prader\u2013Willi syndrome: A comprehensive review and perspectives","volume":"42","author":"Basak","year":"2022","journal-title":"Biosci. Rep."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Fountain, M.D., and Schaaf, C.P. (2016). Prader\u2013Willi Syndrome and Schaaf-Yang Syndrome: Neurodevelopmental Diseases Intersecting at the MAGEL2 Gene. Diseases, 4.","DOI":"10.3390\/diseases4010002"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.ejmg.2016.09.017","article-title":"Prader\u2013Willi syndrome and atypical submicroscopic 15q11-q13 deletions with or without imprinting defects","volume":"59","author":"Hassan","year":"2016","journal-title":"Eur. J. Med. Genet."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Tan, Q., Potter, K.J., Burnett, L.C., Orsso, C.E., Inman, M., Ryman, D.C., and Haqq, A.M. (2020). Prader\u2013Willi-Like Phenotype Caused by an Atypical 15q11.2 Microdeletion. Genes, 11.","DOI":"10.3390\/genes11020128"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/(SICI)1096-8628(19961016)65:2<137::AID-AJMG11>3.0.CO;2-R","article-title":"A 5-year-old white girl with Prader\u2013Willi syndrome and a submicroscopic deletion of chromosome 15q11q13","volume":"65","author":"Butler","year":"1996","journal-title":"Am. J. Med. Genet."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1093\/hmg\/5.4.517","article-title":"Breakage in the SNRPN locus in a balanced 46,XY,t(15;19) Prader\u2013Willi syndrome patient","volume":"5","author":"Sun","year":"1996","journal-title":"Hum. Mol. Genet."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.1002\/ajmg.a.62928","article-title":"Prader\u2013Willi syndrome, deletion subtypes, and magnesium: Potential impact on clinical findings","volume":"188","author":"Butler","year":"2022","journal-title":"Am. J. Med. Genet. A"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/j.1365-2788.2006.00916.x","article-title":"The relationship between compulsive behaviour and academic achievement across the three genetic subtypes of Prader\u2013Willi syndrome","volume":"51","author":"Zarcone","year":"2007","journal-title":"J. Intellect. Disabil. Res."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1186\/s13023-024-03157-2","article-title":"Investigating the correlation between genotype and phenotype in Prader\u2013Willi syndrome: A study of 45 cases from Brazil","volume":"19","author":"Cintra","year":"2024","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_55","first-page":"140","article-title":"Hypopigmentation: A common feature of Prader\u2013Labhart\u2013Willi syndrome","volume":"45","author":"Butler","year":"1989","journal-title":"Am. J. Hum. Genet."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1002\/ajmg.a.61293","article-title":"Impact of genetic subtypes of Prader\u2013Willi syndrome with growth hormone therapy on intelligence and body mass index","volume":"179","author":"Butler","year":"2019","journal-title":"Am. J. Med. Genet. A"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/j.1469-8749.1965.tb07844.x","article-title":"\u201cPuppet\u201d children: A report on three cases","volume":"7","author":"Angelman","year":"1965","journal-title":"Dev. Med. Child Neurol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/ajmg.a.31074","article-title":"Angelman syndrome 2005: Updated consensus for diagnostic criteria","volume":"140","author":"Williams","year":"2006","journal-title":"Am. J. Med. Genet. A"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1002\/ajmg.a.62240","article-title":"Fifty years of recognizable patterns of human malformation: Insights and opportunities","volume":"185","author":"Innes","year":"2021","journal-title":"Am. J. Med. Genet. A"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.seizure.2007.08.004","article-title":"Epilepsy in Angelman syndrome","volume":"17","author":"Pelc","year":"2008","journal-title":"Seizure"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/nrneurol.2016.133","article-title":"Angelman syndrome\u2014Insights into a rare neurogenetic disorder","volume":"12","author":"Buiting","year":"2016","journal-title":"Nat. Rev. Neurol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1136\/jmg.38.12.834","article-title":"Distinct phenotypes distinguish the molecular classes of Angelman syndrome","volume":"38","author":"Lossie","year":"2001","journal-title":"J. Med. Genet."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s11689-023-09504-x","article-title":"Age of diagnosis for children with chromosome 15q syndromes","volume":"15","author":"Wheeler","year":"2023","journal-title":"J. Neurodev. Disord."},{"key":"ref_64","first-page":"100342","article-title":"Genotype-phenotype correlation over time in Angelman syndrome: Researching 134 patients","volume":"5","author":"Fujimoto","year":"2024","journal-title":"HGG Adv."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1007\/s10803-020-04861-1","article-title":"Developmental Skills of Individuals with Angelman Syndrome Assessed Using the Bayley-III","volume":"53","author":"Sadhwani","year":"2023","journal-title":"J. Autism Dev. Disord."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s00439-011-0970-4","article-title":"Microdeletion\/microduplication of proximal 15q11.2 between BP1 and BP2: A susceptibility region for neurological dysfunction including developmental and language delay","volume":"130","author":"Burnside","year":"2011","journal-title":"Hum. Genet."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/jir.12382","article-title":"Clinical and genetic aspects of the 15q11.2 BP1-BP2 microdeletion disorder","volume":"61","author":"Butler","year":"2017","journal-title":"J. Intellect. Disabil. Res."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"2050313X241229058","DOI":"10.1177\/2050313X241229058","article-title":"Late onset psychosis in a case of 15q11.2 BP1-BP2 microdeletion (Burnside-Butler) syndrome: A case report and literature review","volume":"12","author":"Das","year":"2024","journal-title":"SAGE Open Med. Case Rep."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ejmg.2009.03.010","article-title":"Nine patients with a microdeletion 15q11.2 between breakpoints 1 and 2 of the Prader\u2013Willi critical region, possibly associated with behavioural disturbances","volume":"52","author":"Doornbos","year":"2009","journal-title":"Eur. J. Med. Genet."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Ho, K.S., Wassman, E.R., Baxter, A.L., Hensel, C.H., Martin, M.M., Prasad, A., Twede, H., Vanzo, R.J., and Butler, M.G. (2016). Chromosomal Microarray Analysis of Consecutive Individuals with Autism Spectrum Disorders Using an Ultra-High Resolution Chromosomal Microarray Optimized for Neurodevelopmental Disorders. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17122070"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","article-title":"The STRING database in 2023: Protein-protein association networks and functional enrichment analyses for any sequenced genome of interest","volume":"51","author":"Szklarczyk","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"5616","DOI":"10.1073\/pnas.96.10.5616","article-title":"An imprinted, mammalian bicistronic transcript encodes two independent proteins","volume":"96","author":"Gray","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1038\/ejhg.2009.83","article-title":"Expression of SNURF-SNRPN upstream transcripts and epigenetic regulatory genes during human spermatogenesis","volume":"17","author":"Wawrzik","year":"2009","journal-title":"Eur. J. Hum. Genet."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Butler, M.G., Lee, P.D.K., and Whitman, B.Y. (2022). Molecular genetic findings in Prader\u2013Willi syndrome. Management of Prader\u2013Willi Syndrome, Springer Nature. [4th ed.].","DOI":"10.1007\/978-3-030-98171-6"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"e138576","DOI":"10.1172\/jci.insight.138576","article-title":"Loss of MAGEL2 in Prader\u2013Willi syndrome leads to decreased secretory granule and neuropeptide production","volume":"5","author":"Chen","year":"2020","journal-title":"JCI Insight"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1056\/NEJM198102053040604","article-title":"Deletions of chromosome 15 as a cause of the Prader\u2013Willi syndrome","volume":"304","author":"Ledbetter","year":"1981","journal-title":"N. Engl. J. Med."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/S0140-6736(83)92745-9","article-title":"Parental origin of chromosome 15 deletion in Prader\u2013Willi syndrome","volume":"1","author":"Butler","year":"1983","journal-title":"Lancet"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/342281a0","article-title":"Genetic imprinting suggested by maternal heterodisomy in nondeletion Prader\u2013Willi syndrome","volume":"342","author":"Nicholls","year":"1989","journal-title":"Nature"},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Butler, M.G., Hossain, W.A., Cowen, N., and Bhatnagar, A. (2023). Chromosomal Microarray Study in Prader\u2013Willi Syndrome. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24021220"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"e00575","DOI":"10.1002\/mgg3.575","article-title":"Analysis of the Prader\u2013Willi syndrome imprinting center using droplet digital PCR and next-generation whole-exome sequencing","volume":"7","author":"Hartin","year":"2019","journal-title":"Mol. Genet. Genom. Med."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1002\/ajmg.a.38627","article-title":"Three siblings with Prader\u2013Willi syndrome caused by imprinting center microdeletions and review","volume":"176","author":"Hartin","year":"2018","journal-title":"Am. J. Med. Genet. A"},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Strom, S.P., Hossain, W.A., Grigorian, M., Li, M., Fierro, J., Scaringe, W., Yen, H.Y., Teguh, M., Liu, J., and Gao, H. (2021). A Streamlined Approach to Prader\u2013Willi and Angelman Syndrome Molecular Diagnostics. Front. Genet., 12.","DOI":"10.3389\/fgene.2021.608889"},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Mahmoud, R., Kimonis, V., and Butler, M.G. (2022). Genetics of Obesity in Humans: A Clinical Review. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms231911005"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1210\/clinem\/dgad014","article-title":"Diazoxide Choline Extended-Release Tablet in People With Prader\u2013Willi Syndrome: A Double-Blind, Placebo-Controlled Trial","volume":"108","author":"Miller","year":"2023","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"104456","DOI":"10.1016\/j.ejmg.2022.104456","article-title":"Methylation analysis and developmental profile of two individuals with Angelman syndrome due to mosaic imprinting defects","volume":"65","author":"Baker","year":"2022","journal-title":"Eur. J. Med. Genet."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1042\/EBC20190056","article-title":"DNA methylation analysis for screening and diagnostic testing in neurodevelopmental disorders","volume":"63","author":"Godler","year":"2019","journal-title":"Essays Biochem."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"e2141911","DOI":"10.1001\/jamanetworkopen.2021.41911","article-title":"Feasibility of Screening for Chromosome 15 Imprinting Disorders in 16 579 Newborns by Using a Novel Genomic Workflow","volume":"5","author":"Godler","year":"2022","journal-title":"JAMA Netw. Open"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"104690","DOI":"10.1016\/j.ejmg.2022.104690","article-title":"Diagnosis of Prader\u2013Willi syndrome and Angelman syndrome by targeted nanopore long-read sequencing","volume":"66","author":"Yamada","year":"2023","journal-title":"Eur. J. Med. Genet."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1136\/jmg-2024-110115","article-title":"Long-read sequencing for detection and subtyping of Prader\u2013Willi and Angelman syndromes","volume":"62","author":"Akbari","year":"2024","journal-title":"J. Med. Genet."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/ahg.12556","article-title":"NanoImprint: A DNA methylation tool for clinical interpretation and diagnosis of common imprinting disorders using nanopore long-read sequencing","volume":"88","author":"Lester","year":"2024","journal-title":"Ann. Hum. Genet."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s13148-024-01711-0","article-title":"A case of an Angelman-syndrome caused by an intragenic duplication of UBE3A uncovered by adaptive nanopore sequencing","volume":"16","author":"Diederich","year":"2024","journal-title":"Clin. Epigenetics"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13039-016-0233-0","article-title":"Patients with mosaic methylation patterns of the Prader\u2013Willi\/Angelman Syndrome critical region exhibit AS-like phenotypes with some PWS features","volume":"9","author":"Aypar","year":"2016","journal-title":"Mol. Cytogenet."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1002\/ajmg.a.37222","article-title":"A girl with incomplete Prader\u2013Willi syndrome and negative MS-PCR, found to have mosaic maternal UPD-15 at SNP array","volume":"167A","author":"Morandi","year":"2015","journal-title":"Am. J. Med. Genet. A"},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Shahrokhi, S., Baker, E.K., See, M., Ramialison, M., Gamage, D., Rossello, F.J., Heussler, H., Duhig, M., Nicholls, R.D., and Hannan, A.J. (2025). Transcriptomic signatures in brain and blood related to cognitive and psychiatric phenotypes of Prader\u2013Willi syndrome. Sci. Rep., Ahead of print.","DOI":"10.1038\/s41598-025-33041-3"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/s41398-020-01034-7","article-title":"Relationships between UBE3A and SNORD116 expression and features of autism in chromosome 15 imprinting disorders","volume":"10","author":"Baker","year":"2020","journal-title":"Transl. Psychiatry"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"e12992","DOI":"10.1111\/obr.12992","article-title":"Current and emerging therapies for managing hyperphagia and obesity in Prader\u2013Willi syndrome: A narrative review","volume":"21","author":"Tan","year":"2020","journal-title":"Obes. Rev."},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Mahmoud, R., Kimonis, V., and Butler, M.G. (2023). Clinical Trials in Prader\u2013Willi Syndrome: A Review. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24032150"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/YCO.0000000000000391","article-title":"A review of clinical trials of oxytocin in Prader\u2013Willi syndrome","volume":"31","author":"Rice","year":"2018","journal-title":"Curr. Opin. Psychiatry"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/ajmg.b.32401","article-title":"Transcranial direct current stimulation reduces food-craving and measures of hyperphagia behavior in participants with Prader\u2013Willi syndrome","volume":"171","author":"Bravo","year":"2016","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1111\/dom.13021","article-title":"Effects of MetAP2 inhibition on hyperphagia and body weight in Prader\u2013Willi syndrome: A randomized, double-blind, placebo-controlled trial","volume":"19","author":"McCandless","year":"2017","journal-title":"Diabetes Obes. Metab."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1002\/ajmg.a.38160","article-title":"Oxytocin treatment in children with Prader\u2013Willi syndrome: A double-blind, placebo-controlled, crossover study","volume":"173","author":"Miller","year":"2017","journal-title":"Am. J. Med. Genet. A"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"e20162976","DOI":"10.1542\/peds.2016-2976","article-title":"The Use of Oxytocin to Improve Feeding and Social Skills in Infants With Prader\u2013Willi Syndrome","volume":"139","author":"Tauber","year":"2017","journal-title":"Pediatrics"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S2213-8587(25)00161-5","article-title":"New drug approved for hyperphagia in Prader\u2013Willi syndrome","volume":"13","author":"Butler","year":"2025","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1210\/clinem\/dgad015","article-title":"Intranasal Carbetocin Reduces Hyperphagia, Anxiousness, and Distress in Prader\u2013Willi Syndrome: CARE-PWS Phase 3 Trial","volume":"108","author":"Roof","year":"2023","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3390\/diseases3020078","article-title":"Medication Trials for Hyperphagia and Food-Related Behaviors in Prader\u2013Willi Syndrome","volume":"3","author":"Miller","year":"2015","journal-title":"Diseases"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1080\/13543784.2021.1939674","article-title":"Therapies in preclinical and clinical development for Angelman syndrome","volume":"30","author":"Markati","year":"2021","journal-title":"Expert Opin. Investig. Drugs"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"eabf4077","DOI":"10.1126\/scitranslmed.abf4077","article-title":"An ASO therapy for Angelman syndrome that targets an evolutionarily conserved region at the start of the UBE3A-AS transcript","volume":"15","author":"Dindot","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/nature13975","article-title":"Towards a therapy for Angelman syndrome by targeting a long non-coding RNA","volume":"518","author":"Meng","year":"2015","journal-title":"Nature"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nrneurol.2017.148","article-title":"Antisense oligonucleotides: The next frontier for treatment of neurological disorders","volume":"14","author":"Rinaldi","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nature10726","article-title":"Topoisomerase inhibitors unsilence the dormant allele of Ube3a in neurons","volume":"481","author":"Huang","year":"2011","journal-title":"Nature"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/nature12504","article-title":"Topoisomerases facilitate transcription of long genes linked to autism","volume":"501","author":"King","year":"2013","journal-title":"Nature"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13229-018-0228-2","article-title":"Characterization and structure-activity relationships of indenoisoquinoline-derived topoisomerase I inhibitors in unsilencing the dormant Ube3a gene associated with Angelman syndrome","volume":"9","author":"Lee","year":"2018","journal-title":"Mol. Autism"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1007\/s13311-021-01082-x","article-title":"Emerging Gene and Small Molecule Therapies for the Neurodevelopmental Disorder Angelman Syndrome","volume":"18","author":"Copping","year":"2021","journal-title":"Neurotherapeutics"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/s41586-020-2835-2","article-title":"Cas9 gene therapy for Angelman syndrome traps Ube3a-ATS long non-coding RNA","volume":"587","author":"Wolter","year":"2020","journal-title":"Nature"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"e142574","DOI":"10.1172\/JCI142574","article-title":"CRISPR\/Cas9 directed to the Ube3a antisense transcript improves Angelman syndrome phenotype in mice","volume":"131","author":"Schmid","year":"2021","journal-title":"J. Clin. Investig."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1352\/1944-7558-127.2.95","article-title":"The Road to Personalized Therapies: Lessons Learned From Angelman Syndrome","volume":"127","author":"Duis","year":"2022","journal-title":"Am. J. Intellect. Dev. Disabil."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1080\/14737175.2023.2245568","article-title":"Current and emerging treatment options for Angelman syndrome","volume":"23","author":"Keary","year":"2023","journal-title":"Expert Rev. Neurother."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1080\/17512433.2022.2109463","article-title":"Therapeutic approach to neurological manifestations of Angelman syndrome","volume":"15","author":"Ascoli","year":"2022","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"E1072","DOI":"10.1210\/jc.2012-3888","article-title":"GrowthHormone Research Society workshop summary: Consensus guidelines for recombinant human growth hormone therapy in Prader\u2013Willi syndrome","volume":"98","author":"Deal","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/ajmg.a.38582","article-title":"Prader\u2013Willi syndrome and early-onset morbid obesity NIH rare disease consortium: A review of natural history study","volume":"176","author":"Butler","year":"2018","journal-title":"Am. J. Med. Genet. A"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"e00734","DOI":"10.1002\/mgg3.734","article-title":"Healthcare burden among individuals with Angelman syndrome: Findings from the Angelman Syndrome Natural History Study","volume":"7","author":"Khan","year":"2019","journal-title":"Mol. Genet. Genom. Med."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"e1843","DOI":"10.1002\/mgg3.1843","article-title":"A multidisciplinary approach and consensus statement to establish standards of care for Angelman syndrome","volume":"10","author":"Duis","year":"2022","journal-title":"Mol. Genet. Genom. Med."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"274","DOI":"10.21037\/tp.2017.09.04","article-title":"Review of Prader\u2013Willi syndrome: The endocrine approach","volume":"6","author":"Heksch","year":"2017","journal-title":"Transl. Pediatr."},{"key":"ref_124","first-page":"573","article-title":"Alterations in the hypothalamic paraventricular nucleus and its oxytocin neurons (putative satiety cells) in Prader\u2013Willi syndrome: A study of five cases","volume":"80","author":"Swaab","year":"1995","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/ajmg.a.31606","article-title":"Whole genome microarray analysis of gene expression in Prader\u2013Willi syndrome","volume":"143A","author":"Bittel","year":"2007","journal-title":"Am. J. Med. Genet. A"},{"key":"ref_126","doi-asserted-by":"crossref","unstructured":"Forster, J., Duis, J., and Butler, M.G. (2021). Pharmacogenetic Testing of Cytochrome P450 Drug Metabolizing Enzymes in a Case Series of Patients with Prader\u2013Willi Syndrome. Genes, 12.","DOI":"10.3390\/genes12020152"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.pcl.2016.04.006","article-title":"New Therapeutic Approaches to Modulate and Correct Cystic Fibrosis Transmembrane Conductance Regulator","volume":"63","author":"Ong","year":"2016","journal-title":"Pediatr. Clin. N. Am."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa1908639","article-title":"Elexacaftor-Tezacaftor-Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele","volume":"381","author":"Middleton","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_129","doi-asserted-by":"crossref","unstructured":"Butler, M.G., Silvey, S., and van Bosse, H.J.P. (2025). Barriers, Limitations, and Experiences with Clinical Trials-Treatment in Rare Diseases with Prader\u2013Willi Syndrome as an Example. Genes, 16.","DOI":"10.3390\/genes16121436"},{"key":"ref_130","doi-asserted-by":"crossref","unstructured":"Forster, J., Duis, J., and Butler, M.G. (2020). Pharmacodynamic Gene Testing in Prader\u2013Willi Syndrome. Front. Genet., 11.","DOI":"10.3389\/fgene.2020.579609"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/3\/1270\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T05:16:08Z","timestamp":1769750168000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/3\/1270"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,27]]},"references-count":130,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["ijms27031270"],"URL":"https:\/\/doi.org\/10.3390\/ijms27031270","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,27]]}}}